|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號:P210928 |
| 產(chǎn)品名稱:Pazopanib- (13CD3) Hydrochloride Salt |
| 產(chǎn)品CAS:1261398-44-0 |
| 規(guī)格含量:10mg |
| 產(chǎn)品價(jià)格:面議 |
| 聯(lián)系我們: |
|
|
|
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號: |
P210928 |
| 名稱: |
Pazopanib- (13CD3) Hydrochloride Salt |
| CAS號: |
1261398-44-0 |
| 分子式: |
C??¹³CH??D?N?O?S • (HCl) |
| 分子量: |
441.533646 |
| 類別: |
Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
Pazopanib-(13CD3) Hydrochloride Salt is the isotope labelled analog of Pazopanib (P210925), an oral angiogenesis inhibitor targeting VEGFR and PDGFR. |
| 參考文獻(xiàn) |
|
|
|
|